Mandibular advancement device versus continuous positive airway pressure for treatment of obstruvtive sleep apnea syndrome: a randomized crossover trial Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
A randomised, double-blind, crossover, placebo-controlled trial of a mandibular advancement device for the treatment of snoring and mild obstructive sleep apnoea-hypopnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002
Efficacy of mandibular advancement appliance in moderate obstructive sleep apnea syndrome. A prospective randomised study Source: Annual Congress 2010 - The upper airway and oral appliances Year: 2010
Clinical and cost-effectiveness of a mandibular advancement device versus continuous positive airway pressure in moderate obstructive sleep apnea: a randomized controlled trial Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018
The role of CPAP treatment in elderly patients with moderate obstructive sleep apnoea: a multicentre randomised controlled trial Source: Eur Respir J, 54 (2) 1900518; 10.1183/13993003.00518-2019 Year: 2019
Randomised controlled trial of the effect of CPAP in uncontrolled nocturnal asthmatic patients with OSAS. Source: International Congress 2017 – CPAP therapy Year: 2017
A randomised, controlled clinical trial using acoustic parameters of snoring sound as objective outcomes of palatal surgery for snoring Source: Eur Respir J 2002; 20: Suppl. 38, 561s Year: 2002
Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019 Year: 2020
A double-blind double dummy randomised placebo-controlled cross-over design clinical trial of formoterol delivered by two different dry powder devices in prevention of bronchoconstriction induced by methacholine in mild to moderate persistent asthma in adult patients Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009
Nasal vs oronasal interface during exercise under noninvasive ventilation in COPD: A randomized cross-over study Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018
Mandibular advancement therapy does not reduce inflammatory and metabolic biomarkers in patients with severe OSA: a randomized controlled trial Source: International Congress 2018 – Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement Year: 2018
High flow nasal cannula during walking in severe COPD patients: a randomized controlled trial. Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018
Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Efficacy of an open nasal cannula system (TNI) to treat obstructive sleep apnea – results from a clinical multi-center trial Source: Annual Congress 2008 - Innovative treatments in sleep disordered breathing Year: 2008
Non-CPAP therapies in obstructive sleep apnoea: mandibular advancement device therapy Source: Eur Respir J 2012; 39: 1241-1247 Year: 2012
Prospective evaluation of a thermoplastic mandibular advancement device in 20 patients with sleep related breathing disorders Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002
A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma Source: Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017 Year: 2018
A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019
Domiciliary high-flow nasal cannula oxygen therapy for stable hypercapnic chronic obstructive pulmonary disease: a prospective, multicentre, randomised crossover trial Source: International Congress 2017 – New insights in chronic respiratory failure Year: 2017
Safety and efficacy of sulthiame in moderate to severe obstructive sleep apnea: a randomized placebo-controlled parallel-group trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021